Daplo (Dr.Reddy’s brand of dapagliflozin) is 100% Bio-equivalent to Innovator. There is NO Bio-variability with Daplo, More than 70% of Drug released from tablet in 20 min. Daplo has a Superior packaging which ensures greater protection. POTECT HEART. PROETCT KIDNEYS of every Diabetes patient with Daplo & Daplo M.

 

Dapagliflozin helps get rid of excess glucose from body through urine. Lowering blood glucose levels is an essential part of managing diabetes. It can also be taken together with other diabetes medicines when a single medicine is not controlling your blood sugar properly.

Dapagliflozin reduces the risk of hospitalization for heart failure in adults with type 2 diabetes mellitus and either established cardiovascular (CV) disease or multiple CV risk factors.

Dapagliflozin reduces the risk of sustained eGFR decline, end‑stage kidney disease, cardiovascular death, and hospitalization for heart failure in adults with chronic kidney disease at risk of progression.

Dapagliflozin reduces the risk of cardiovascular death and hospitalization for heart failure in adults with heart failure (NYHA class II-IV) with reduced ejection fraction.